Adrian Jun Chu

Dr. Adrian Jun Chu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JYJiqing Ye
Jiqing Ye
ACAdrian Jun Chu
Adrian Jun Chu
RHRachel Harper
Rachel Harper
SCShu Ting Chan
Shu Ting Chan
TSTsun Lam Shek
Tsun Lam Shek
CMCong Ma
Cong Ma

18 August 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JYJiqing Ye
Jiqing Ye
ACAdrian Jun Chu
Adrian Jun Chu
LLLin Lin
Lin Lin
SCShu Ting Chan
Shu Ting Chan
RHRachel Harper
Rachel Harper
XYXiao Yang
Xiao Yang

Verified
Journal Article
Open access
PDF file
ACAdrian Jun Chu
Adrian Jun Chu
YQYangyi Qiu
Yangyi Qiu
RHRachel Harper
Rachel Harper
LLLin Lin
Lin Lin
CMCong Ma
Cong Ma
XYXiao Yang
Xiao Yang
The emergence of multidrug resistance in the clinically significant pathogen Staphylococcus aureus is a global health burden, compounded by a diminishing drug development pipeline, and a lack of approved novel antimicrobials. Our previously reported first-in-class bacterial transcription inhibitors “nusbiarylins” presented a promising prospect towards the discovery of novel antimicrobial agents with a novel mechanism. Here we investigated and characterised the lead nusbiarylin compound, MC4, and several of its chemical derivatives in both methicillin-resistant S. aureus (MRSA) and the S. aureus type strains, demonstrating their capacity for the arrest of growth and cellular respiration, impairment of RNA and intracellular protein levels at subinhibitory concentrations. In some instances, derivatives of MC4 were also shown to attenuate the production of staphylococcal virulence factors in vitro, such as the exoproteins α-toxin and Panton–Valentine Leukocidin (PVL). Trends observed from quantitative PCR assays suggested that nusbiarylins elicited these effects possibly by acting via but not limited to the modulation of global regulatory pathways, such as the agr regulon, which coordinates the expression of S. aureus genes associated with virulence. Our findings encourage the continued development of more potent compounds within this novel family of bacterial transcription inhibitors.

9 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
JYJiqing Ye
Jiqing Ye
ACAdrian Jun Chu
Adrian Jun Chu
LLLin Lin
Lin Lin
XYXiao Yang
Xiao Yang
CMCong Ma
Cong Ma
Novel antimicrobial classes are in desperate need for clinical management of infections caused by increasingly prevalent multi-drug resistant pathogens. The protein-protein interaction between bacterial RNA polymerase (RNAP) and the housekeeping sigma initiation factor is essential to transcription and bacterial viability. It also presents a potential target for antimicrobial discovery, for which a hit compound (C3) was previously identified from a pharmacophore model-based in silico screen. In this study, the hit compound was experimentally assessed with some rationally designed derivatives for the antimicrobial activities, in particular against Streptococcus pneumoniae and other pathogens. One compound, C3-005, shows dramatically improved activity against pneumococci compared to C3. C3-005 also attenuates S. pneumoniae toxin production more strongly than existing classes of antibiotics tested. Here we demonstrate a newly validated antimicrobial agent to address an overlooked target in the hit-to-lead process, which may pave the way for further antimicrobial development.

21 August 2024 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
NLNga Man Lam
Nga Man Lam
TTTsz Fung Tsang
Tsz Fung Tsang
JQJiayi Qu
Jiayi Qu
MTMan Wai Tsang
Man Wai Tsang
YTYuan Tao
Yuan Tao
XYXiao Yang
Xiao Yang
Mechanistic investigations are of paramount importance in elucidating the modes of action of antibiotics and facilitating the discovery of novel drugs. We reported a luciferase-based reporter system using bacterial cells to unveil mechanisms of antimicrobials targeting transcription and translation. The reporter gene Nluc encoding NanoLuciferase (NanoLuc) was integrated into the genome of the Gram-positive model organism, Bacillus subtilis , to generate a reporter strain BS2019. Cellular transcription and translation levels were assessed by quantifying the amount of Nluc mRNA as well as the luminescence catalyzed by the enzyme NanoLuc. We validated this system using three known inhibitors of transcription (rifampicin), translation (chloramphenicol), and cell wall synthesis (ampicillin). The B. subtilis reporter strain BS2019 successfully revealed a decline in Nluc expression by rifampicin and NanoLuc enzyme activity by chloramphenicol, while ampicillin produced no observable effect. The assay was employed to characterize a previously discovered bacterial transcription inhibitor, CUHK242, with known antimicrobial activity against drug-resistant Staphylococcus aureus . Production of Nluc mRNA in our reporter BS2019 was suppressed in the presence of CUHK242, demonstrating the usefulness of the construct, which provides a simple way to study the mechanism of potential antibiotic candidates at early stages of drug discovery. The reporter system can also be modified by adopting different promoters and reporter genes to extend its scope of contribution to other fields of work. IMPORTANCE: Discovering new classes of antibiotics is desperately needed to combat the emergence of multidrug-resistant pathogens. To facilitate the drug discovery process, a simple cell-based assay for mechanistic studies is essential to characterize antimicrobial candidates. In this work, we developed a luciferase-based reporter system to quantify the transcriptional and translational effects of potential compounds and validated our system using two currently marketed drugs. Reporter strains generated in this study provide readily available means for identifying bacterial transcription inhibitors as prospective novel antibacterials. We also provided a series of plasmids for characterizing promoters under various conditions such as stress.

22 May 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
TWTin Yan Wong
Tin Yan Wong
LZLichun Zhang
Lichun Zhang
TWThomas Chun Yip Wong
Thomas Chun Yip Wong
CYChun Ngo Yau
Chun Ngo Yau
ACAdrian Jun Chu
Adrian Jun Chu
HLHei Ming Lai
Hei Ming Lai
Chaotropes are long known to destabilise protein assemblies and folding. We report that a boron cluster ion, as a weakly coordinating superchaotrope, can paradoxically stabilise protein folding even under extended thermal stresses, while broadly inhibiting specific and non-specific protein-protein interactions at millimolar concentrations. Thermodynamic and kinetic investigations suggest that the boron cluster ion reduced the association rates of protein association and rendered protein-associative interactions entropically unfavourable. The preliminary utility of this phenomenon is demonstrated by the preservation of protein functions within complex mixtures stored in ambient, uncontrolled conditions, boosting their shelf-life and stability against aggregation.